Please Wait
Applying Filters...

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Ousia Pharma is a University of Copenhagen spin-out developing next-generation peptide-drug conjugates for obesity and metabolic diseases. Our proprietary platform uses targeted peptides to deliver synaptic plasticity modulators, enabling potent, sustained weight loss with enhanced safety. We are advancing our lead candidate, OP-56, as a transformative therapy for general obesity.

List your booth number for exhibitions, ask us